Nelfinavir

  • Part D specialty tier in 77% of formularies (2026Q3)
  • VIRACEPT

Therapy management checklist

Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.

Loading the therapy management checklist…

Storage and cold chain

Nelfinavir: storage and handling

Freezing
Not addressed
Room temperature
No allowance stated
Back into the refrigerator
Not addressed
Light
Not addressed
Shaking
Not addressed

Temperature excursion helper

Answers only from this label's storage statements. It does not judge whether a product is still usable beyond what the label states.

The label does not state a room-temperature allowance for this product.

Entered: 1 day at up to 77°F (25°C).

Contact the manufacturer at 1-800-438-1985 (the number printed on the label) about this product.

Where the label prints this number
VIRACEPT is a registered trademark of Agouron Pharmaceuticals, LLC For more information, call 1-800-438-1985.
All storage statements on the label (4)
  • VIRACEPT tablets and oral powder should be stored at 15° to 30°C (59° to 86°F).
  • How should I store VIRACEPT? .
  • Store VIRACEPT Tablets and Oral Powder at room temperature, between 59ºF to 86ºF (15ºC to 30ºC). .
  • Store VIRACEPT in the original container. .

FDA label version 35, effective December 11, 2025. DailyMed

Dosing and titration calendar

Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.

Loading dosing schedules…

Medicare Part D coverage

100%of plans list it
0%of those: prior authorization
0%step therapy
55%quantity limit
80%specialty tier

5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan

Patient assistance

No manufacturer program page is listed for this drug yet.

Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.

For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.